104 related articles for article (PubMed ID: 21095442)
21. Update in immunosuppression.
Huizinga R
Nephrol Nurs J; 2002 Jun; 29(3):261-7. PubMed ID: 12164076
[TBL] [Abstract][Full Text] [Related]
22. Immunopharmacologic therapy in renal transplantation.
Shoker AS
Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
[TBL] [Abstract][Full Text] [Related]
23. Renal transplantation.
Catto G
Practitioner; 1991 Feb; 235(1499):162, 164-5, 167. PubMed ID: 2034583
[No Abstract] [Full Text] [Related]
24. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immunosuppressive protocols in renal transplantation: a multicenter view.
Opelz G
Transplant Proc; 1988 Dec; 20(6 Suppl 8):31-6. PubMed ID: 3059620
[No Abstract] [Full Text] [Related]
26. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
27. [Cyclosporin in transplantation management--especially after kidney transplantation].
Quellhorst E
Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
[No Abstract] [Full Text] [Related]
28. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998.
Seikaly M; Ho PL; Emmett L; Tejani A
Pediatr Transplant; 2001 Jun; 5(3):215-31. PubMed ID: 11422826
[TBL] [Abstract][Full Text] [Related]
29. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
Hanto DW; Chudzinski R
Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
[No Abstract] [Full Text] [Related]
30. Improving the success of organ transplantation.
Carpenter CB
N Engl J Med; 2000 Mar; 342(9):647-8. PubMed ID: 10699165
[No Abstract] [Full Text] [Related]
31. Immunosuppressive protocols at transplantation centers in Turkey.
Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
[No Abstract] [Full Text] [Related]
32. Immunosuppression in high-risk transplantation.
Rhee J; Al-Mana N; Freeman R
Curr Opin Organ Transplant; 2009 Dec; 14(6):636-42. PubMed ID: 19812495
[TBL] [Abstract][Full Text] [Related]
33. How can we improve the long-term outcome after pediatric organ transplantation?
Debray D
Curr Opin Organ Transplant; 2010 Oct; 15(5):588-9. PubMed ID: 20689434
[No Abstract] [Full Text] [Related]
34. [Initial 2-year results of the treatment of patients after kidney transplantation at the Szczecin center].
Lapis J; Switlik I; Umiński M; Zieliński S
Wiad Lek; 1987 Mar; 40(6):428-31. PubMed ID: 3307155
[No Abstract] [Full Text] [Related]
35. Management of chronic allograft dysfunction by switch over to rapamycin.
Sundaram V; Abraham G; Fathima N; Sundaram V; Reddy YN; Mathew M; Sathiah V
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):37-42. PubMed ID: 20061690
[TBL] [Abstract][Full Text] [Related]
36. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Wali RK; Weir MR
Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
[TBL] [Abstract][Full Text] [Related]
37. Improved graft survival after renal transplantation in the United States, 1988 to 1996.
Sam R; Leehey DJ
N Engl J Med; 2000 Jun; 342(24):1837-8. PubMed ID: 10866557
[No Abstract] [Full Text] [Related]
38. Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients.
Kuypers DR
Clin Pharmacol Ther; 2010 Nov; 88(5):595-6; author reply 597. PubMed ID: 20664539
[No Abstract] [Full Text] [Related]
39. Advances in immunosuppression for renal transplantation.
Durrbach A; Francois H; Beaudreuil S; Jacquet A; Charpentier B
Nat Rev Nephrol; 2010 Mar; 6(3):160-7. PubMed ID: 20125095
[TBL] [Abstract][Full Text] [Related]
40. [The autoimmune thyroiditis with subclinicsal thyreotoxicosis in the immunosupressed patient with renal transplant].
Magomedov AG; Abdulkhalikov AS; Akhmedov IG; Osmanov OM
Khirurgiia (Mosk); 2012; (6):53-4. PubMed ID: 22951616
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
